Key Record Dates
ClinicalTrials.gov Identifier: | NCT04260217 |
---|---|
Brief Title: | APG-2575 Single Agent or in Combination With Ibrutinib or Rituximab in Patients With Waldenström Macroglobulinemia (MAPLE-1) |
First Submitted : | February 5, 2020 |
First Submitted that Met QC Criteria : | February 5, 2020 |
First Posted : | February 7, 2020 |
Last Update Submitted that Met QC Criteria : | January 31, 2023 |
Last Update Posted : | February 1, 2023 |